KeyBanc analyst Ken Newman raised the firm’s price target on Cognex (CGNX) to $80 from $70 and keeps an Overweight rating on the shares following quarterly results. The firm thinks Cognex is clearly benefiting from the early stages of a short-cycle inflection, which has been magnified by ongoing cost-out benefits. While KeyBanc acknowledges lumpy nuances in Q3 sales due to order timing and prior-year one-time benefits, the firm continues to see potential upside to consensus estimates into the second half of 2026 and 2027 from further momentum in organic volumes and additional productivity initiatives.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CGNX:
